Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
31,179,158
-
Share change
-
-8,767,301
-
Total reported value
-
$42,369,792
-
Put/Call ratio
-
60%
-
Price per share
-
$1.35
-
Number of holders
-
57
-
Value change
-
-$20,800,165
-
Number of buys
-
29
-
Number of sells
-
30
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q4 2021
As of 31 Dec 2021,
Aptose Biosciences Inc. - Common Shares was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,179,158 shares.
The largest 10 holders included
DRW Securities, LLC, Nantahala Capital Management, LLC, 683 Capital Management, LLC, SANDERS MORRIS HARRIS LLC, CARLSON CAPITAL L P, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP, and BNP PARIBAS ARBITRAGE, SA.
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.